Evidence map›Paper›PMID 24608430›Full record

ArticleOncogene2015

The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers.

L Chung, D Onyango, Z Guo, P Jia, H Dai, S Liu, M Zhou, W Lin, I Pang, H Li and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

L ChungDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
D OnyangoDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
Z Guo1] Department of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA [2] Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
P JiaWWAMI Medical Education Program, School of Molecular Biosciences, Washington State University, Spokane, WA, USA.
H DaiDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
S Liu1] Department of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA [2] College of Life Science, Zhejiang University, Hangzhou, Zhejiang 310058, China.
M ZhouDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
W LinDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
I PangDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
H LiDepartment of Molecular Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
Y-C YuanDepartment of Molecular Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
Q HuangDepartment of Pathology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
L ZhengDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
J Lopes1] Section de Recherche, Institut Curie, CNRS UMR3244, Paris, France [2] Muséum National d'Histoire Naturelle, USM 503, INSERM U565, UMR7196, Paris, France.
A NicolasSection de Recherche, Institut Curie, CNRS UMR3244, Paris, France.
W ChaiWWAMI Medical Education Program, School of Molecular Biosciences, Washington State University, Spokane, WA, USA.
D RazDepartment of Surgery, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
K L ReckampDepartment of Medical Oncology and Therapeutics Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
B ShenDepartment of Radiation Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
City Of Hope National Medical Center · USCentre National de la Recherche Scientifique · FRWashington State University Spokane · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Function Analysis of FEN-1 Nuclease in Genome StabilityR01CA073764 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI BINGHUI SHEN · 2002 to 2026
$7.9M
Mechanisms of Fork Restart in Response to Genotoxic StressR01GM112864 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CHAI, WEIHANG · 2014 to 2018
$1.5M
STRUCTURE/FUNCTION OF A DNA REPAIR ENDONUCLEASER29CA073764 · NCI · CITY OF HOPE NATIONAL MEDICAL CENTER · PI SHEN, BINGHUI · 1997 to 2001
$264k
NCI NIH HHS CA073764NCI NIH HHS P30 CA033572NCI NIH HHS P30CA033572NCI NIH HHS R01 CA073764NIGMS NIH HHS R01 GM112864
6 · The paper itself

Abstract

Polymorphisms and somatic mutations in Flap Endonuclease 1 (FEN1), an essential enzyme involved in DNA replication and repair, can lead to functional deficiencies of the FEN1 protein and a predisposition to cancer. We identified a FEN1 germline mutation that changed residue E359 to K in a patient whose family had a history of breast cancer. We determined that the E359K mutation, which is in the protein-protein domain of FEN1, abolished the interaction of FEN1 with Werner syndrome protein (WRN), an interaction that is critical for resolving stalled DNA replication forks. Furthermore, although the flap endonuclease activity of FEN1 E359K was unaffected, it failed to resolve bubble structures, which require the FEN1 gap-dependent endonuclease activity. To determine the etiological significance of E359K, we established a mouse model containing this mutation. E359K mouse embryonic fibroblasts (MEF) were more sensitive to DNA crosslinking agents that cause replication forks to stall. Cytological analysis suggested that the FEN1-WRN interaction was also required for telomere stability; mutant cell lines had fragile telomeres, increased numbers of spontaneous chromosomal anomalies and higher frequencies of transformation. Moreover, the incidence of cancer was significantly higher in mice homozygous for FEN1 E359K than in wild-type mice, suggesting that the FEN1 E359K mutation is oncogenic.

Indexed as

AneuploidyExodeoxyribonucleasesFlap EndonucleasesMutation, MissenseNeoplasms, ExperimentalRecQ HelicasesAmino Acid SubstitutionAnimalsCell LineDNA, NeoplasmDNA ReplicationEmbryo, MammalianFemaleFibroblastsHumansMiceDNA, NeoplasmExodeoxyribonucleasesFEN1 protein, humanFen1 protein, mouseFlap EndonucleasesRecQ HelicasesWerner Syndrome HelicaseWRN protein, humanWrn protein, mouse

Identifiers

PMID24608430
PMCPMC4160428
OpenAlexW2032135885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.